Mega Lifesciences PCL (BKK:MEGA)
33.00
+0.25 (0.76%)
Oct 15, 2026, 4:36 PM ICT
Mega Lifesciences PCL Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Mega Lifesciences PCL stock has a consensus rating of "Strong Buy" and an average price target of ฿42.71. The average 1-year stock price forecast is 29.42% higher than the current stock price, while the lowest is ฿35.00 (+6.06%) and the highest is ฿45.00 (+36.36%).
Price Target: ฿42.71 (+29.42%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Mega Lifesciences PCL stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 1 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Financial Forecast
Revenue This Year
14.33B
from 14.19B
Increased by 0.96%
Revenue Next Year
15.50B
from 14.33B
Increased by 8.16%
EPS This Year
2.52
from 2.34
Increased by 7.80%
EPS Next Year
2.85
from 2.52
Increased by 13.12%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is THB.